-
Imagine Dragons frontman chases childhood video game dream
-
Teenage sprint star Gout powers to 200m win in blistering 19.67sec
-
China's energy strategy pays off as Mideast war cramps supplies: analysts
-
Hungarians vote in closely watched election, with Orban's rule on line
-
Mideast war takes a bite out of Filipino street food vendors
-
Crime-weary Peru votes for ninth president in a decade
-
Vance says talks failed to reach deal with Iran on ending Mideast war
-
New York's teen spirit frustrates Messi, Miami
-
Vance says talks failed to reach agreement with Iran
-
'Stop hiring humans'? Silicon Valley confronts AI job panic
-
Force rue missed opportunities after another Super Rugby defeat
-
Ireland's Lowry becomes first with two Masters aces
-
'Mental toughness' hailed after Reds snap 15-year Crusaders curse
-
Justin Bieber fans flood Coachella festival for headlining show
-
Saturday charge has Young in sight of first major title at Masters
-
McIlroy looking for answers after squandered Masters lead
-
McIlroy and Young share lead after Masters third round
-
Lavelle marks 100th cap with goal in US win over Japan
-
Artemis crew urges unity on 'lifeboat' Earth
-
US, Iran talks extend into second day as strait showdown deepens
-
Former heavyweight king Fury outpoints Makhmudov, calls out Joshua
-
Former heavyweight king Fury outpoints Makhmudov on ring return
-
Two-time champ Scheffler surges up Masters leaderboard
-
McIlroy scrambles to hold off rivals and keep Masters lead
-
Milan's Serie A title hopes in tatters after shock Udinese defeat, Juve fourth
-
Easter truce between Russia and Ukraine falters
-
US warships transit Strait of Hormuz in mine clearance op
-
Playoff seedings on line as grueling NBA regular-season comes to close
-
Ngumoha's 'special' impact no surprise to Slot
-
Arsenal suffer major title blow as Liverpool earn vital win
-
US, Iran hold high-level peace talks in Pakistan
-
Over 200 arrested at pro-Palestinian rally in London
-
McIlroy tees off with six-stroke Masters lead
-
Record-breaking Bayern march closer to Bundesliga title
-
World champions England make winning start to Women's Six Nations
-
Yamal shines as Barca thrash Espanyol to extend Liga lead
-
Drean double sets Toulon up for Champions Cup semi against Leinster
-
Salah, Ngumoha ease Liverpool crisis with Fulham win
-
Arsenal suffer huge title blow as Liverpool earn vital win
-
Samson smashes hundred as Chennai notch first win of IPL season
-
Bayern Munich set Bundesliga record with 102nd goal of season
-
Milan's Serie A title hopes in tatters after shock Udinese defeat
-
Alcaraz and Sinner battle for No.1 spot in Monte Carlo final
-
In fiery speech, Pope Leo says 'Enough to war!'
-
Andreeva to face Potapova in Linz WTA final
-
Holders Italy, Britain into BJK Cup finals, USA knocked out
-
Arsenal suffer title 'punch' by Bournemouth, Everton hold Brentford
-
Drean double breaks Glasgow hearts as Toulon reach Champions Cup semis
-
Teen star Seixas seals Basque Tour triumph, August wins sixth stage
-
Scores arrested at pro-Palestinian rally in London
Featured
Last news
ALT5 Sigma Corporation Announces Record Date for Alyea Therapeutics Corporation Transaction
LAS VEGAS, NEVADA / ACCESS Newswire / May 21, 2025 / ALT5 Sigma Corporation (the "Company" or "ALT5") (NASDAQ:ALTS)(FRA:5AR1), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, today announces June 2, 2025 as the record date for the previously announced transaction involving further steps in the Company's formal separation of its healthcare assets, known as Alyea Therapeutics Corporation ("Alyea"). As previously announced, the Company has decided to separate its healthcare and fintech segments to allow each entity to concentrate on its unique business needs.
Google ramps up AI features in search engine
Google on Tuesday said it was beefing up online searches with even more generative artificial intelligence, as it presses on with embracing AI despite fears for its ad-based business model.
Pascal Hinnen Joins Kleinfelder as Executive Vice President and Central Division Director
SAN DIEGO, CA / ACCESS Newswire / May 20, 2025 / The Kleinfelder Group, Inc. ("Kleinfelder"), a leading engineering, design, construction management, construction materials inspection and testing, and environmental professional services firm, announced today that Pascal Hinnen, PE, has joined the firm as Executive Vice President and Central Division Director. Hinnen will oversee operations throughout Kleinfelder's Central Division, providing leadership focused on sustained growth and operational excellence.
Arrive AI Inks Deal with Go2 Delivery Setting the Stage for Secure Medication Delivery in Virginia
Arrive AI technology poised to bring autonomous delivery to Hampton Roads, Richmond and Norfolk ahead of other locations
Cytta Corp. Formally Launches Cytta Labs, Repositions as IP-Holding Platform Backed by TrueWealth(TM) Vision and Strategic Studio Model
Cytta Labs Begins Aggressive Public Spinout Program with Two New Special Purpose Vehicles
1606 Corp. Announces Transition to OTCID Tier, Marking a Major Step for the Company
PHOENIX, ARIZONA / ACCESS Newswire / May 20, 2025 / 1606 Corp. (OTC:CBDW) (the "Company") is pleased to announce that, effective July 1, 2025, the Company will be moving from the OTC Pink to the OTC ID designation within the OTC Markets platform. This upgrade represents a meaningful advancement in the Company's transparency, regulatory compliance, and overall market visibility as it continues to position itself for long-term growth.
Amaze Named Exclusive Merchandise Partner for Ghost Gaming as Creator Economy Expands
Fans Can Shop Official Merchandise from Ghost Gaming, with Exclusive Designs Launching at DreamHack Dallas May 23-25
Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting
LAS VEGAS, NV / ACCESS Newswire / May 20, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are in talks with an international healthcare innovation company to license or potentially acquire its patented early disease detection technology. If successful, it's a global license or acquisition that has the potential to revolutionize preventive health reporting and to generate correlations for future detection of new diseases without the need for all the patient's data.
Cambridge Isotope Laboratories Launches ISOLED-D: Revolutionary Deuterated Reagents for OLED Manufacturing
New ISOLED-D™ line delivers premium, scalable deuterated reagents for OLED synthesis, supporting the industry from R&D through commercial production with CIL's global manufacturing and expertise.
Coder Wins 2025 AI TechAward for Best Innovation in AI Integration: Business-to-Business
AI software development company recognized for excellence in developer technology
Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22
SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, is pleased to invite investors to a webinar on May 22, 2025, at 4:15 p.m. ET.
Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer
With more than $10m in cash, and a significantly reduced burn rate, the Company is positioned to fully fund the development of its technology platform.
Tonner One World Eliminates Over $700,000 in Toxic Debt, Signs Agreement to Acquire $1.3M Revenue-Generating Company, and Outlines Strategy for Growth and Market Advancement
With major debt eliminated, revenue-accretive acquisitions underway, and new AI tools in development, Tonner signals a transformative leap in its operational and shareholder value strategy.
Paragon Board Responds to Gad's Latest Misleading Statements - Shareholders Deserve the Truth
Gad Continues Pattern of Lying to Shareholders and Misrepresenting the Facts
CXApp Inc. (Nasdaq: CXAI) Reports Strong Q1'25 Customer Success Metrics and Adoption of Agentic AI based CXAI Platform
Highest Subscription Revenue Ratio (99%) and Gross Margin (88%) with 3 large customer expansion renewals at 130%+CXAI Kiosk and CXAI VU being utilized for RTO (Return-to-Office) initiatives across large enterprises
BlackBerry to Participate in Upcoming Investor Events
BlackBerry Executives to speak at upcoming Baird and Wells Fargo conferences
Polar bear biopsies to shed light on Arctic pollutants
With one foot braced on the helicopter's landing skid, a veterinarian lifted his air rifle, took aim and fired a tranquiliser dart at a polar bear.
Aspira Announces First Quarter 2025 Financial Results and Provides Business Update
AUSTIN, TX / ACCESS Newswire / May 19, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announced today its results of operations for the three-month period ended March 31, 2025. The Company also reported early progress under its new leadership team. Key financial highlights for the quarter are summarized below:
Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
BRIDGEWATER, NJ / ACCESS Newswire / May 19, 2025 / Tharimmune, Inc. (Nasdaq:THAR), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced the appointment of James Gordon Liddy (CDR US Navy SEAL (Ret)) as a strategic advisor. Mr. Liddy, an internationally recognized expert on counterterrorism and critical infrastructure protection, will provide invaluable guidance as Tharimmune advances the development of TH104, its lead program for temporary prophylaxis against respiratory and/or central nervous system depression in military personnel and chemical incident responders exposed to high-potency opioids, including potential weaponized agents like fentanyl.
enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer
IRVINE, CA / ACCESS Newswire / May 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, announced the appointment of Jennifer Bright as Chief Financial Officer, effective today, May 19, 2025. Ms. Bright brings more than 25 years of financial and strategic leadership experience built across several commercial-stage medical device and pharmaceutical companies including Biolase, Spectrum Pharmaceuticals, Apria Healthcare, Smile Brands, and Teleflex Medical, as well as technical accounting and auditing experience at PricewaterhouseCoopers LLP.
Visium Technologies Secures Landmark $20 Million Contract for National Data Centers in West Africa
Contract Announced at AmCham Business Summit
Applied Energetics Announces Appointment of Kevin Gunde, PhD, as Senior Vice President, Head of Engineering
TUCSON, AZ / ACCESS Newswire / May 19, 2025 / Applied Energetics, Inc. (OTCQB:AERG), a company engaged in the development of advanced optical technologies and pulsed laser systems, today announced the appointment of Kevin Gunde, PhD, a veteran executive and scientist with over 30 years of leadership experience in the defense sector and intelligence domain, as its Head of Engineering, effective immediately. Dr. Gunde joined the Company's Advisory Board in September of 2022 and since then transitioned to Senior Advisor. Throughout his career, Dr. Gunde has led teams which specialize in development, deployment, productization and the transfer of innovative technologies from research laboratories to the operational elements of the defense and intelligence communities.
Arrive AI and Hancock Health Launch Robotic Medical Deliveries at Hancock Regional Hospital
Groundbreaking Automation Poised to Deliver Enhanced Efficiency and Patient CareMarks Arrive AI's First Revenue Generating Arrive PointTM Deployment
BroadSat and WidePoint Build a Dome of Defense with Secure EdgeAI for Smart Cities and Federal Networks
Partnership combines cybersecurity, EdgeAI, and broadcast broadband to create a Dome of Defense for mission-critical applications and connected environments across smart cities, defense, and federal networks.
Swarmer and SpiderOak Partner to Secure Autonomous Drone Operations in Contested Environments
Strategic collaboration delivers zero-trust security and resiliency for military autonomous swarm operations, including those deployed in electronic warfare zones
5 Top Rated Gold IRA Companies in 2025 (Best Gold IRA Companies List Released)
IRAEmpire.com has released an updated list of the best gold IRA companies of 2025.
Affluence Corporation Completes Acquisition of Mingothings SLU
Strategic acquisition to expand market reach and ensure profitable growth.
The Critical Need for Governance, Risk, and Compliance in Healthcare AI
TAMPA, FL / ACCESS Newswire / May 19, 2025 / As artificial intelligence (AI) transforms healthcare, organizations face unprecedented opportunities-and risks. From clinical decision support to patient engagement, AI-enabled technologies promise efficiency and innovation. However, without robust governance, risk management, and compliance (GRC) frameworks, these advancements can lead to ethical dilemmas, regulatory violations, and patient harm. Newton3, a Tampa-based strategic advisory firm, specializes in helping healthcare leaders navigate this complex landscape, ensuring AI deployments are both impactful and accountable.
CAVU Resources, Inc. Reports 1st Quarter Results and Has a One Time Net Gain of $1,236,216
TULSA, OK / ACCESS Newswire / May 19, 2025 / CAVU Resources, Inc. (OTC PINK:CAVR) CAVU releases its First Quarter 2025 earnings report and is pleased to announce that the first quarter reflects a one-time net gain of $1,236,216, compared to a gain of $125,169 for the same period in 2024. For the three-month period, revenue increased by $1,111,047, representing a 887% increase year over year.
Global chip giants converge on Taiwan for Computex
Global semiconductor chip giants will gather at Taiwan's top tech expo this week to showcase "the next frontier" for an industry dominated by artificial intelligence.
Eurovision favourite KAJ shines spotlight on Finland's Swedish- speaking minority
Comedy act KAJ, the favourite to win Saturday's Eurovision Song Contest for Sweden, has shone a spotlight on Finland's small Swedish-speaking minority, little-known outside the Nordic region, Finnish officials say.
Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
NEW YORK CITY, NEW YORK / ACCESS Newswire / May 16, 2025 / Bionoid Pharma Inc. (OTC PINK:BINP) proudly announces its corporate rebranding to AI Maverick Intel, Inc., marking a significant transformation in its strategic direction. This change underscores the company's commitment to leveraging advanced artificial intelligence technologies to revolutionize customer acquisition and engagement across healthcare, biotech, and other sectors.